GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 381 filers reported holding GUARDANT HEALTH INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $939,143 | -14.6% | 31,685 | +3.1% | 0.01% | -11.1% |
| Q2 2023 | $1,100,134 | +66.5% | 30,730 | +9.0% | 0.01% | +50.0% |
| Q1 2023 | $660,938 | -6.4% | 28,197 | +8.6% | 0.01% | -14.3% |
| Q4 2022 | $706,085 | -47.4% | 25,959 | +4.1% | 0.01% | -50.0% |
| Q3 2022 | $1,342,000 | +33.9% | 24,928 | +0.3% | 0.01% | +40.0% |
| Q2 2022 | $1,002,000 | -35.2% | 24,845 | +6.4% | 0.01% | -16.7% |
| Q1 2022 | $1,547,000 | -33.3% | 23,357 | +0.8% | 0.01% | -33.3% |
| Q4 2021 | $2,318,000 | -20.8% | 23,175 | -1.0% | 0.02% | -25.0% |
| Q3 2021 | $2,927,000 | +1.6% | 23,413 | +0.9% | 0.02% | +4.3% |
| Q2 2021 | $2,882,000 | -13.5% | 23,204 | +6.3% | 0.02% | -20.7% |
| Q1 2021 | $3,332,000 | +19.6% | 21,827 | +0.9% | 0.03% | +16.0% |
| Q4 2020 | $2,787,000 | +45.6% | 21,625 | +26.3% | 0.02% | +31.6% |
| Q3 2020 | $1,914,000 | +84.7% | 17,123 | +34.1% | 0.02% | +26.7% |
| Q2 2020 | $1,036,000 | +68.7% | 12,765 | +44.8% | 0.02% | +36.4% |
| Q1 2020 | $614,000 | – | 8,818 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |